Geron Corp
GERN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886744
No open-market purchases or sales by Geron Corp insiders were filed in the last 90 days; 260 institutions reported holding it in 13F filings for Q2 2026, worth $610.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Geron Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- +7 vs. Q4 2022
- Shares held
- 325.5M
- +117.1M (+56.2%) vs. Q4 2022
- Total value
- $706.4M
- +$198.5M (+39.1%) vs. Q4 2022
- New holders
- 41
- 77 more added
- Sold out
- 34
- 35 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 260 | $610.5M |
| Q1 2026 | 256 | $740.7M |
| Q4 2025 | 262 | $631.7M |
| Q3 2025 | 263 | $694.7M |
| Q2 2025 | 259 | $725.4M |
| Q1 2025 | 270 | $811.6M |
| Q4 2024 | 285 | $1.73B |
| Q3 2024 | 255 | $2.31B |
| Q2 2024 | 239 | $1.97B |
| Q1 2024 | 231 | $1.43B |
| Q4 2023 | 202 | $830.0M |
| Q3 2023 | 202 | $786.9M |
| Q2 2023 | 201 | $1.10B |
| Q1 2023 | 191 | $706.4M |
| Q4 2022 | 185 | $509.1M |
| Q3 2022 | 180 | $447.8M |
| Q2 2022 | 154 | $299.0M |
| Q1 2022 | 150 | $247.1M |
| Q4 2021 | 147 | $156.5M |
| Q3 2021 | 139 | $179.0M |
| Q2 2021 | 145 | $181.6M |
| Q1 2021 | 146 | $225.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Geron Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Matisse Capital | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| WESPAC Advisors, LLC | 0 | $0 | 0.00% | −108,640−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −101,782−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −70,964−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −48,487−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −38,228−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −27,757−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −21,612−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −20,512−100.0% | Sold out |
| Merit Financial Group, LLC | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| OmniStar Financial Group, Inc. | 0 | $0 | 0.00% | −10,760−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −10,559−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −8,901−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Archer Investment Corp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| MinichMacGregor Wealth Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Annapolis Financial Services, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Estabrook Capital Management | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| HealthCor Management, L.P. | – | – | – | – | Not filed |